Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused...
27 KB (2,911 words) - 19:56, 27 October 2024
(developed by GSK plc) and Abrysvo (Pfizer). The prophylactic use of palivizumab or nirsevimab (both are monoclonal antibody treatments) can prevent RSV...
98 KB (9,650 words) - 14:14, 6 November 2024
study showed that nirsevimab had a similar safety profile compared to palivizumab (Synagis). The US Food and Drug Administration (FDA) evaluated the safety...
24 KB (1,917 words) - 17:27, 12 October 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
10 KB (778 words) - 01:56, 27 September 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
91 KB (9,261 words) - 06:16, 10 November 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
79 KB (6,427 words) - 02:51, 8 November 2024
Passive antibody therapy (section Palivizumab)
large-cell lymphoma in 2011. In 1998, the FDA approved the medical use of palivizumab (trade name: Synagis), which is a humanized monoclonal antibody used...
27 KB (2,923 words) - 15:03, 4 April 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
16 KB (1,284 words) - 04:32, 23 September 2024
increased risk factors for infection with RSV. A second monoclonal antibody, Palivizumab, can be administered to prevent bronchiolitis to infants less than one...
53 KB (5,627 words) - 15:24, 8 November 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
42 KB (3,486 words) - 00:32, 30 September 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
56 KB (5,566 words) - 13:30, 2 November 2024
inhibitor, and has shown good results in Phase II and III clinical trials. Palivizumab Presatovir Lumicitabine Zheng X, Gao L, Wang L, Liang C, Wang B, Liu...
3 KB (171 words) - 19:10, 25 January 2023
pandemic immunotherapy, targets spike protein of SARS-CoV-2 human Other palivizumab RSV infections in children inhibits an RSV fusion (F) protein humanized...
48 KB (4,964 words) - 04:26, 20 October 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
42 KB (3,798 words) - 21:12, 26 October 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
31 KB (2,632 words) - 22:56, 26 October 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
10 KB (703 words) - 17:18, 20 April 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
10 KB (836 words) - 03:56, 30 September 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
27 KB (2,336 words) - 05:02, 27 October 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
31 KB (2,777 words) - 08:32, 19 October 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
86 KB (7,962 words) - 21:38, 10 November 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
8 KB (511 words) - 15:46, 7 September 2024
J06BC02 Raxibacumab J06BC03 Bezlotoxumab J06BC04 Obiltoxaximab J06BD01 Palivizumab J06BD02 Motavizumab J06BD03 Tixagevimab and cilgavimab J06BD04 Ansuvimab...
2 KB (264 words) - 07:33, 31 December 2022
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
53 KB (4,975 words) - 03:43, 30 September 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
6 KB (352 words) - 17:16, 16 May 2024
59% Novo Nordisk Diabetes mellitus type 2 May-1909 Mon-20XX 47 Synagis Palivizumab 289,704 0.00% MedImmune RSV infection Feb-1998 Aug-2012 48 Avonex Interferon...
29 KB (281 words) - 06:29, 12 August 2024
drugs that use monoclonal antibodies include ZMapp against Ebola and Palivizumab against RSV. Many mABs against other infections are in clinical trials...
32 KB (3,494 words) - 00:52, 30 July 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
214 KB (17,080 words) - 15:51, 27 September 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
10 KB (724 words) - 06:09, 16 July 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
10 KB (799 words) - 13:28, 4 September 2024
Isosorbide mononitrate Metoprolol Motavizumab Olaparib Omeprazole Osimertinib Palivizumab Propofol Quetiapine Ravulizumab Roflumilast Rosuvastatin Roxadustat...
41 KB (3,278 words) - 04:56, 27 October 2024